Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis

NCT00317499 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis
Psoriasis

Interventions

OTHER: Placebo
DRUG: Etanercept

Sponsor

Amgen

Collaborators

[object Object]